EP1539191A4 - Glycoalkaloid-zusammensetzungen und verschiedene anwendungen - Google Patents

Glycoalkaloid-zusammensetzungen und verschiedene anwendungen

Info

Publication number
EP1539191A4
EP1539191A4 EP03732115A EP03732115A EP1539191A4 EP 1539191 A4 EP1539191 A4 EP 1539191A4 EP 03732115 A EP03732115 A EP 03732115A EP 03732115 A EP03732115 A EP 03732115A EP 1539191 A4 EP1539191 A4 EP 1539191A4
Authority
EP
European Patent Office
Prior art keywords
various uses
glycoalkaloid
compositions
glycoalkaloid compositions
various
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03732115A
Other languages
English (en)
French (fr)
Other versions
EP1539191A1 (de
Inventor
Stephen John Carter
Elizabeth Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solbec Pharmaceuticals Ltd
Original Assignee
Solbec Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solbec Pharmaceuticals Ltd filed Critical Solbec Pharmaceuticals Ltd
Publication of EP1539191A1 publication Critical patent/EP1539191A1/de
Publication of EP1539191A4 publication Critical patent/EP1539191A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
EP03732115A 2002-07-01 2003-06-24 Glycoalkaloid-zusammensetzungen und verschiedene anwendungen Withdrawn EP1539191A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPS3290A AUPS329002A0 (en) 2002-07-01 2002-07-01 Glycoalkaloid compositions and various uses thereof
AUPS329002 2002-07-01
PCT/AU2003/000788 WO2004002497A1 (en) 2002-07-01 2003-06-24 Glycoalkaloid compositions and various uses thereof

Publications (2)

Publication Number Publication Date
EP1539191A1 EP1539191A1 (de) 2005-06-15
EP1539191A4 true EP1539191A4 (de) 2007-03-21

Family

ID=3836847

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03732115A Withdrawn EP1539191A4 (de) 2002-07-01 2003-06-24 Glycoalkaloid-zusammensetzungen und verschiedene anwendungen

Country Status (5)

Country Link
EP (1) EP1539191A4 (de)
AU (3) AUPS329002A0 (de)
CA (1) CA2489675A1 (de)
NZ (1) NZ537267A (de)
WO (1) WO2004002497A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003900194A0 (en) * 2003-01-15 2003-01-30 Solbec Pharmaceuticals Limited Methods of modulating il-6
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
WO2006092017A1 (en) * 2005-03-02 2006-09-08 Solbec Pharmaceuticals Limited Glycoalkaloid and tlr agonist combinations and various uses thereof
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
WO2008064425A1 (en) * 2006-11-30 2008-06-05 Solbec Pharmaceuticals Limited Glycoalkaloid and chemotherapeutic agent combinations and various uses thereof
TWI414304B (zh) * 2011-05-04 2013-11-11 G & E Herbal Biotechnology Co Ltd 使用茄屬植物的水溶性萃取物來治療疣
TWI476012B (zh) 2011-05-12 2015-03-11 G & E Herbal Biotechnology Co Ltd 使用茄屬植物的水溶性萃取物來治療和／或預防發炎與皮膚光損害以及光防護皮膚
CN102872260A (zh) * 2011-06-10 2013-01-16 德英生物科技股份有限公司 使用茄属植物的水溶性萃取物来治疗和/或预防发炎与皮肤光损害以及光防护皮肤
CN111303239B (zh) * 2020-03-02 2022-03-01 河南中医药大学 两种治疗食管癌的活性单体、组合物及其应用
CN114306361A (zh) * 2021-11-29 2022-04-12 成都大学 Khasianine在制备用于预防和/或治疗炎症性疾病药物中的用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0020029A1 (de) * 1979-05-02 1980-12-10 Aruba (Qld.) Pty. Ltd. Pharmazeutische Zusammensetzungen enthaltende Steroidalkaloidderivate
WO2003029269A1 (en) * 2001-09-28 2003-04-10 Glycomed Sciences Limited Solvent extraction process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU540812B2 (en) * 1979-05-02 1984-12-06 Aruba Qld Pty. Ltd. Steroid alkaloids
WO1991010743A1 (en) * 1990-01-18 1991-07-25 Cura Nominees Pty Ltd Glycoalkaloids
AU779512B2 (en) * 1999-04-09 2005-01-27 Cura Nominees Pty Ltd Medicinal compositions and their method of preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0020029A1 (de) * 1979-05-02 1980-12-10 Aruba (Qld.) Pty. Ltd. Pharmazeutische Zusammensetzungen enthaltende Steroidalkaloidderivate
WO2003029269A1 (en) * 2001-09-28 2003-04-10 Glycomed Sciences Limited Solvent extraction process

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2004002497A1 *

Also Published As

Publication number Publication date
WO2004002497A1 (en) 2004-01-08
AU2009202266A1 (en) 2009-08-06
CA2489675A1 (en) 2004-01-08
AU2003238544A1 (en) 2004-01-19
NZ537267A (en) 2006-11-30
AUPS329002A0 (en) 2002-07-18
EP1539191A1 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
IL169441A0 (en) Hemostatic compositions and uses therefor
AU2003231107A8 (en) Detergent compositions and components thereof
AU2002357119A8 (en) Mitocidal compositions and methods
EP1539941A4 (de) Adzyme und deren verwendungen
EP1487965A4 (de) Minizellzusammensetzungen und -verfahren
IL168386A (en) Compositions and uses of lycopene
AU2003218121A8 (en) Lotion compositions
IL166331A0 (en) 5-arylterazole compounds compositions thereof and uses therefor
GB0208081D0 (en) Skincare compositions and methods
AU2003275268A8 (en) Hemostatic compositions and methods
GB2393963B (en) Sliding composition and sliding member
GB0214805D0 (en) Cosmetic compositions
GB0222843D0 (en) Microbicidal compositions and their use
EP1539191A4 (de) Glycoalkaloid-zusammensetzungen und verschiedene anwendungen
SI1551805T1 (sl) Substituirani gama-fenil-delta-laktami in njihova uporaba
AU2003213120A8 (en) Human rnase iii and compositions and uses thereof
AU2002357748A8 (en) Osteopontin-related compositions and methods
GB2384705B (en) Cosmetic and related compositions
TWI350750B (en) Compositions comprising cyclohexylamines and aminoadamantanes
GB0314469D0 (en) Antimicrobial compositions and uses thereof
PT1390074T (pt) Novas composições e suas utilizações
AU2003231827A8 (en) Pseudo-tissues and uses thereof
GB0207224D0 (en) Tenascin-W compositions and uses thereof
AU2003228896A8 (en) Anti-microbial peptides and compositions
GB0325942D0 (en) Compositions and uses thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050127

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20070221

17Q First examination report despatched

Effective date: 20070905

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RTI1 Title (correction)

Free format text: GLYCOALKALOID COMPOSITION AND USES THEREOF

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090203